Patents by Inventor Pierre Tchoreloff

Pierre Tchoreloff has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200163879
    Abstract: The invention relates to a process for the manufacture of a tablet comprising a nucleic acid vector.
    Type: Application
    Filed: May 9, 2018
    Publication date: May 28, 2020
    Inventors: VIRGINIE BUSIGNIES-GODDIN, PASCAL BIGEY, CHRISTINE CHARRUEAU, VIRGINIE ESCRIOU, PIERRE TCHORELOFF
  • Publication number: 20200155621
    Abstract: The disclosure relates to a mucoadhesive sustained-release vaginal tablet including at least one probiotic strain of the genus Lactobacillus compressed with an excipient suitable for conferring upon the tablet the properties of vaginal wall mucoadhesion and sustained release.
    Type: Application
    Filed: June 25, 2019
    Publication date: May 21, 2020
    Inventors: Claudia THORAL, Pierre TCHORELOFF, Vincent MAZEL, Virginie BUSIGNIES, Adrien NIVOLIEZ
  • Publication number: 20170014458
    Abstract: The disclosure relates to a mucoadhesive sustained-release vaginal tablet including at least one probiotic strain of the genus Lactobacillus compressed with an excipient suitable for conferring upon the tablet the properties of vaginal wall mucoadhesion and sustained release.
    Type: Application
    Filed: March 10, 2015
    Publication date: January 19, 2017
    Applicant: BIOSE
    Inventors: Claudia THORAL, Pierre TCHORELOFF, Vincent MAZEL, Virginie BUSIGNIES, Adrien NIVOLIEZ
  • Publication number: 20130039982
    Abstract: The invention concerns a microgranule tablet comprising a low dose of active principle containing a directly compressible diluent. The invention is characterised in that the directly compressible diluent consists exclusively of neutral microgranules, and the active principle is set on the neutral microgranules and is not coated with an agent designed to modify its release or mask its taste.
    Type: Application
    Filed: August 16, 2012
    Publication date: February 14, 2013
    Applicant: ETHYPHARM
    Inventors: Guy Couaraze, Bernard Leclerc, Pierre Tchoreloff, Patrick Sanial
  • Patent number: 8337892
    Abstract: The invention concerns a microgranule tablet comprising a low dose of active principle containing a directly compressible diluent. The invention is characterized in that the directly compressible diluent consists exclusively of neutral microgranules, and the active principle is set on the neutral microgranules and is not coated with an agent designed to modify its release or mask its taste.
    Type: Grant
    Filed: July 25, 2000
    Date of Patent: December 25, 2012
    Assignee: ETHYPHARM
    Inventors: Guy Couaraze, Bernard Leclerc, Pierre Tchoreloff, Patrick Sanial
  • Patent number: 8029825
    Abstract: The invention relates to low-dose tablets obtained by directly compressing microgranules essentially constituted of a neutral support covered by a polymeric layer containing at least one pharmaceutically acceptable polymer and permitting the modified release of active substances in an aqueous medium, to which an active layer containing at least one active substance is applied. The inventive tablets advantageously exhibit a matrix effect similar to that obtained with conventional matrix tablets that depends on the nature of the polymer(s) used for the constitution of the polymeric layer. This matrix effect makes it possible to modify the release profile of the transported active substance based on the type of the polymer used. These tablets are particularly suited for realizing low-dose tablets. The invention also relates to a method for producing these tablets and to the use thereof, particularly for administering active substances in low to very low doses.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: October 4, 2011
    Assignee: Ethypharm
    Inventors: Pierre Tchoreloff, Bernard Leclerc, Guillaume Benoist, Laurent Bertocchi
  • Publication number: 20080031946
    Abstract: The invention relates to low-dose tablets obtained by directly compressing microgranules essentially constituted of a neutral support covered by a polymeric layer containing at least one pharmaceutically acceptable polymer and permitting the modified release of active substances in an aqueous medium, to which an active layer containing at least one active substance is applied. The inventive tablets advantageously exhibit a matrix effect similar to that obtained with conventional matrix tablets that depends on the nature of the polymer(s) used for the constitution of the polymeric layer. This matrix effect makes it possible to modify the release profile of the transported active substance based on the type of the polymer used. These tablets are particularly suited for realizing low-dose tablets. The invention also relates to a method for producing these tablets and to the use thereof, particularly for administering active substances in low to very low doses.
    Type: Application
    Filed: November 10, 2004
    Publication date: February 7, 2008
    Applicant: ETHYPHARM
    Inventors: Pierre Tchoreloff, Bernard Leclerc, Guillaume Benoist, Laurent Bertocchi